SEARCH

MENU

treatments

Browse the results of this Tag below
Donanemab

New Alzheimer’s Drug Donanemab Offers Hope for Treating Dementia

A new experimental Alzheimer’s drug called donanemab is generating major excitement as a potential breakthrough ...
Read More →
Ketamine

Pearls for Clinical, Ketamine

Amidst a burgeoning body of research, we’re continually unravelling new facets of the versatile drug ...
Read More →
Advancements in Clinical Trials for Lymphoma Cancer Patients

Advancements in Clinical Trials for Lymphoma Cancer Patients

Lymphoma cancer is a type of cancer that affects the lymphatic system, which is responsible ...
Read More →
Lilly Bets $630M on Pain Target Novartis Failed: A High-Stakes Gamble in the World of Pharma

Lilly’s £630M Investment in Novartis’ Failed Pain Target.

In the highly competitive world of pharmaceuticals, companies are constantly looking for the next big ...
Read More →
Sin título-3

Lecanemab, an Alzheimer’s medication, is heralded as a major development.

It has been called “historic” that the first drug to slow the brain damage caused ...
Read More →
Mark Cuban's new pharmacy is bringing down the cost of medications

Mark Cuban’s new pharmacy is bringing down the cost of meds

It is still attempting to resolve the fundamental issue. In general, Mark Cuban’s new online ...
Read More →